Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01441687 · ClinicalTrials.gov registry record · NA
Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy Outcome
A NA study of Healthy and Prostate Cancer, sponsored by City of Hope Medical Center.
- Active
- Registry status
- NA
- Development phase
- 243
- Enrollment target
- 5
- Study locations
NCT01441687 is a NA study of Healthy and Prostate Cancer that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 243 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (62% lower). The trial reports 5 study locations across 1 state.
The verdict
NCT01441687, a NA study of Healthy and Prostate Cancer, is active but no longer recruiting, sponsored by City of Hope Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 243 participants
- Enrollment target
- 5
- Study locations
Study Summary
This randomized pilot phase I trial studies the best way, either expressed prostatic secretion (EPS) or post massage urine (PMU) biomarkers, of predicting biopsy results in patients undergoing prostate biopsy. Studying samples of urine in the laboratory may help doctors detect prostate cancer. It is not yet known whether EPS or PMU biomarkers are more effective in predicting prostate biopsy results
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
- PROCEDURE transrectal prostate biopsy
Study Locations (5)
California
- Chinn & Chinn Urology Associates, Inc. - Arcadia
- City of Hope Medical Center - Duarte
- Citrus Valley Urologic Medical Group - Glendora
- Dr. Felix Chi-Ming Yip - Monterey Park
- City of Hope- South Pasadena Cancer Center - South Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 243 participants |
| Start Date | 2009-07-14 |
| Est. Completion | 2027-02-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01441687
The ClinicalTrials.gov registry entry for NCT01441687 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 243 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (62% lower). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which laboratory biomarker analysis is the first listed.
NCT01441687 reports 5 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01441687 about?
NCT01441687 is a clinical study titled "Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy Outcome". This randomized pilot phase I trial studies the best way, either expressed prostatic secretion (EPS) or post massage urine (PMU) biomarkers, of predicting biopsy results in patients undergoing prostate biopsy. Studying samples of urine in the laboratory may help doctors detect prostate cancer. It is...
What is the current status of trial NCT01441687?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 243 participants. The study started on 2009-07-14. Estimated completion is 2027-02-03.
What conditions does trial NCT01441687 study?
This clinical trial studies the following conditions: Healthy, Prostate Cancer, Conditions Influencing Health Status.
What interventions are being tested in trial NCT01441687?
The interventions under investigation include: laboratory biomarker analysis (OTHER), transrectal prostate biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01441687?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01441687 being conducted?
This trial has 5 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.